|
|
|
 |
FDA Approval Activities for this Drug…
ISONIAZID Injection 100MG/ML NYDRAZID APOTHECON 088235 ISONIAZID Syrup; 50MG/5ML ISONIAZID CAROLINA MEDCL 083633 ISONIAZID Tablet; 300MG ISONIAZID AXIOM 080936 ISONIAZID Tablet; 100MG ISONIAZID Barr 080937 ISONIAZID Tablet; 300MG ISONIAZID Barr 088119 ISONIAZID Tablet; 300MG ISONIAZID DURAMED Barr 008678 ISONIAZID Tablet; 100MG ISONIAZID Eon 008678 ISONIAZID Tablet; 300MG ISONIAZID Eon 080140 ISONIAZID Tablet; 100MG LANIAZID LANNETT 089776 ISONIAZID Tablet; 300MG LANIAZID LANNETT 080140 ISONIAZID Tablet; 50MG LANIAZID LANNETT 040090 ISONIAZID Tablet; 100MG ISONIAZID Mikart 040090 ISONIAZID Tablet; 300MG ISONIAZID Mikart 080521 ISONIAZID Tablet; 300MG ISONIAZID Watson 080212 ISONIAZID Tablet; 100MG ISONIAZID West Ward 087425 ISONIAZID Tablet; 300MG ISONIAZID West Ward 050705 ISONIAZID; PYRAZINAMIDE; RIFAMPIN Tablet; 50MG;300MG;120MG RIFATER AVENTIS 061884 ISONIAZID; RIFAMPIN Capsule; 150MG;300MG RIFAMATE AVENTIS | Rifater (rifampin, isoniazid and pyrazinamide) Tablets, Aventis Pharma, Labeling Revision | Isoniazid Injection, Sabex 2002, Approval | Rifampin and Isoniazid Capsules, West-ward Pharma, Approval | Isoniazid Tablets, Sandoz Inc., Labeling Revision | Rifater (isoniazid, pyrazinamide and rifampin) Tablets, Sanofi-aventis U.S. LLC, Labeling Revision | Rifater (rifampin, isoniazid and pyrazinamide), Tablets, Sanofi-Aventis U.S. LLC, Labeling Revision
  
|